[Echocardiographic assessment of left atrial volume and emptying in hypertrophic cardiomyopathy]

Ewa Michalak1, Janina Małgorzata Michalak, Lidia Chojnowska

  • 1Klinika Wad Wrodzonych Serca, Instytut Kardiologii, Warszawa. emichalak@eko.net.pl

Przeglad Lekarski
|February 24, 2005
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) causes left atrial (LA) enlargement and altered emptying dynamics. While total LA emptying fraction remains similar, active emptying increases, with a negative correlation to mitral regurgitation in HCM patients.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Imaging

Background:

  • Left ventricular diastolic dysfunction is a key factor in hypertrophic cardiomyopathy (HCM) symptom development.
  • Abnormal left ventricular (LV) filling in HCM is theorized to cause left atrial (LA) enlargement and impaired emptying.

Purpose of the Study:

  • To investigate left atrial (LA) volumes and emptying dynamics in patients with hypertrophic cardiomyopathy (HCM) using 2D echocardiography.
  • To assess differences in LA size and function between HCM patients and healthy controls.

Main Methods:

  • Utilized 2D echocardiography with automatic borderline detection to measure LA volumes (LAVmax, LAV-RE, LAV-P, LAVmin) and emptying fractions (%LAEF, delta LAV-RE, delta LAV-AC).
  • Compared these parameters between 27 HCM patients and 38 healthy volunteers.
  • Calculated mitral regurgitation fraction in HCM patients.

Main Results:

  • HCM patients exhibited significantly larger maximal, end-rapid emptying, pre-atrial contraction, and minimal LA volumes compared to controls.
  • Active LA emptying (delta LAV-AC) was significantly greater in HCM patients.
  • Total LA emptying fraction (%LAEF), passive emptying volume change (delta LAV-RE), and the passive/active emptying ratio were similar between groups.
  • A significant negative correlation was found between mitral regurgitation fraction and total LA emptying fraction (%LAEF) in HCM patients.

Conclusions:

  • Left ventricular hypertrophy in HCM leads to significant left atrial enlargement and altered emptying patterns.
  • Despite LA volume changes, the overall LA emptying efficiency is preserved in HCM.
  • No correlation was observed between the degree of LV hypertrophy and LA volume or emptying parameters.
  • Mitral regurgitation influences LA total emptying fraction, warranting further investigation.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...